The National Health and Health Commission issued a document, 57 drugs into the key monitoring list

Medicine Network December 31 just, the National Health and Safety Commission issued a paper, 57 drugs into the key monitoring list focused on monitoring 57 vulnerable drugs December 29, the National Health and Safety Commission issued "on the issuance of the national list of drugs in short supply notice" and at the same time issued "national list of drugs in short supply" and "national clinically necessary drugs in short supply key monitoring list."
According to Cypress Blue combing, the national list of shortage drugs included a total of 6 drugs, namely methotrexate, pituitary retinal injection, penicillin, mitothoquine, Xenon, sodium thiopental.
National list of clinically necessary and vulnerable drugs includes a total of 57 drugs, such as penicillin, chlorpyridine, allopurin, dixie, nitrate glycerin, dicosin, deacetyl hair flower glycoside, epinephrine, atophan, dopamine, fish protein, agasmine, fissin, chrysanthemum, and so on.
is worth noting that the shortage of nitrate glycerin, fish protein, glycoside and other drugs has also caused more patient concern.
However, the National Health and Safety Commission also pointed out that, with the shortage of medicine supply security system gradually established and improved, China's drug shortage contradictions have been alleviated, large-scale, long-term shortage is less, mainly temporary, local shortage.
In selecting the national list of drugs, the main factors to consider are: first, clinically necessary, irreplaceable or irreplaceable varieties; At the same time, according to the summary information, comprehensive consideration of expert argumentation and the current actual drug demand and grass-roots level of protection, taking into account the oral dosage form;
2018, the state has begun to start inventory research demonstration work.
list plays an important role in promoting and increasing the enthusiasm of enterprises in production, promoting the implementation of policies such as procurement and supply, production stoppage reports and reserves, and strengthening drug stocks on the list of medical institutions.
specifically, the national list is based on the provincial list, which contains six varieties of medicines in short supply, with a focus on addressing the shortage at the production and supply ends and ensuring the supply of medicines.
There are 57 varieties on the national list of priority monitoring lists of clinically necessary and vulnerable medicines, focusing on clinically necessary and irreplaceable or irreplaceable medicines at risk of supply shortages, monitoring and mastering the availability and use of medicines, early warning, and taking timely measures to prevent shortages from occurring.
, taking into account document 47's requirement for focused monitoring and dynamic tracking of medicines on the national list, six shortages of medicines were included in the focus of monitoring.
national list includes 48 injection forms and 10 oral dosage forms (of which glyceal nitrate includes injection and oral dosage forms) and will be dynamically adjusted in the actual availability of the drugs in short supply.
To combat the monopoly of raw materials and drugs, multi-measures to ensure supply in the notice, the National Health and Safety Commission requires: First, the implementation of procurement policies, to ensure the supply of shortage of drugs at the provincial level shortage of drug supply guarantee mechanism lead units will work with the relevant departments, combined with the actual situation, to ensure stable prices, the implementation of the national list of drugs in the provincial drug and medical supplies centralized procurement platform directly linked to the network, according to the provisions of the record and other procurement policies, to achieve price transparency.
in the national list, the original procurement policy is implemented in principle for the shortage of medicines that have been addressed in the region.
All departments should respond in a timely manner in accordance with their duties, explore and improve the centralized procurement of shortage drugs, normal reserves and other work, the production and supply of national list drugs in accordance with the law into the scope of credit evaluation and supervision, do a good job in monitoring the national list of drugs, to ensure that the shortage of drugs supply work smoothly.
The National Health and Health Commission in the policy interpretation section said that for clinically necessary drugs in short supply of key monitoring list and shortage of drugs in the list of drugs, provincial drug centralized procurement platform no enterprises listed or not included in the province's centralized procurement catalog, medical institutions may put forward procurement needs, offline search for pharmaceutical production enterprises, and directly negotiate with drug supply enterprises, in accordance with the principle of fairness to determine the procurement price, centralized procurement platform at the provincial level for independent filing, to achieve transparency.
, we should optimize the structure of central and local medicine reserves and increase the shortage of medicines.
, implement the legal provisions, the implementation of the shortage of drugs to stop production report drug market license holders in accordance with the relevant provisions of the national list of drugs in short supply to implement the shutdown report.
the provincial drug regulatory department where the project is located receives the report, it shall promptly inform the provincial linkage mechanism lead unit.
the lead unit of the provincial linkage mechanism receives the report of the relevant shortage of drugs, it shall report the discontinued varieties, the stop-off time, the reason for the shutdown, the expected resumption of production time, the supply and use of the province to the National Health and Health Commission.
Health Commission of the United States shall, in due course, inform the member units and localities of the National Linkage Mechanism on the reporting of the discontinuation of shortage drugs.
. Improve relevant measures to strengthen the supply of shortage of drug reserves to provincial pharmaceutical reserve management departments to sort out the national list of drugs that have been included in the provincial medical reserve catalogue, and regularly inform the provincial linkage mechanism lead units of the reserve varieties.
the provincial linkage mechanism will work with the pharmaceutical reserve management department to establish a shortage of drug call procedures in line with local real conditions.
to guide the concentration of small varieties of drugs (shortage drugs) production base to actively safeguard the production and supply of drugs on the national list.
the provincial linkage mechanism lead units should work with relevant departments to do a good job in the national list of drugs supply security work.
, the Ministry of Security of the Xinjiang and Tibet Military Regions and the regional joint security agencies shall be responsible for coordinating the supply of medicines on the national list of military medical institutions in the region in accordance with the unified deployment requirements of the provincial linkage mechanisms.
In addition, according to Document No. 47, the Administrative Measures and the Notice, the relevant departments will, in accordance with their duties, strengthen the monitoring and early warning of price anomalies of drugs on the national list, strengthen the normal supervision of prices, increase law enforcement of illegal acts such as the monopoly of raw materials, and classify and properly deal with the problem of abnormal drug prices.
All departments should respond in a timely manner in accordance with their duties, explore and improve the centralized procurement of shortage drugs, normal reserves and other work, the production and supply of national list drugs in accordance with the law into the scope of credit evaluation and supervision, the implementation of the shortage of drugs stop production report, do a good job in the national list of drug monitoring work, to ensure that the shortage of drug supply work smoothly.
。